A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science presented today at the ...

Polygenic risk scores (PRSs) are a cutting-edge tool in genetics, combining information from genetic markers across the ...

Vaderis Therapeutics AG (Vaderis), a clinical stage biotechnology company focusing on treatments for rare diseases associated with ...

Haslam family to the Cleveland Clinic will help provide genetic testing for patients, promote cardiovascular genetics ...

The WATCHMAN implant provides an alternative treatment to reduce stroke risk for individuals with non-valvular ... The ...

“As dementia cannot be reversed with any medications, a nonpharmacologic approach, such as lifestyle modification, is ...